1920 Yonge Street, Suite 200
Toronto, Ontario, Canada, M4S 3E2
AntoXa is a Canadian biotechnology company focused on developing, manufacturing and commercializing innovative drugs for defence applications. AntoXa’s medical countermeasures are produced using a rapid, low-cost plant-based system that ensures high-quality drug products. AntoXa is developing medical countermeasures against chemical (Nerve gas) and biological threats (Ricin), and nerve trauma, which have significant potential for harm in civilian and military situations.
AntoXa is committed to producing high-value biopharmaceuticals to meet demand for safe, effective medical countermeasures against chemical and biological agents as well as naturally occurring outbreaks of infectious disease. Our goal is to save lives by protecting military personnel and civilians from emerging global threats to national security and public health.